Susan E. Siegel
Susan (Sue) E, Siegel was elected as a director of Align in May 2017. Since 2012, Ms. Siegel has been CEO of GE Ventures, General Electric’s growth and innovation business. Ms. Siegel has 30+ years of experience within corporate companies and venture capital firms. Prior to GE Ventures, Ms. Siegel was a General Partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health, and life sciences. Before venture capital, she served as president and board member at Affymetrix and drove the company’s transformation from a pre-revenue start up to a global, multi-billion dollar market cap genomics leader. Prior to Affymetrix, Ms. Siegel led strategy, technology development, licensing, manufacturing, as well as new market creation & development at Bio-Rad, DuPont, and Amersham. Ms. Siegel holds a M.S. in Biochemistry and Molecular Biology from Boston University Medical School and a B.S. in Biology from the University of Puerto Rico. She currently serves on the boards of the National Venture Capital Association, MIT’s The Engine, RAND Health, Stanford Medicine’s Board of Leaders, University of California’s Innovation Council, Harvard Partners’ Innovation Advisory Board, and USC’s Schaeffer Center for Health Policy. She is an Aspen Institute Crown Fellow.